Amino Acids

, Volume 31, Issue 3, pp 251–272 | Cite as

The role of substance P in stress and anxiety responses

  • K. Ebner
  • N. Singewald
Review Article


Substance P (SP) is one of the most abundant peptides in the central nervous system and has been implicated in a variety of physiological and pathophysiological processes including stress regulation, as well as affective and anxiety-related behaviour. Consistent with these functions, SP and its preferred neurokinin 1 (NK1) receptor has been found within brain areas known to be involved in the regulation of stress and anxiety responses. Aversive and stressful stimuli have been shown repeatedly to change SP brain tissue content, as well as NK1 receptor binding. More recently it has been demonstrated that emotional stressors increase SP efflux in specific limbic structures such as amygdala and septum and that the magnitude of this effect depends on the severity of the stressor. Depending on the brain area, an increase in intracerebral SP concentration (mimicked by SP microinjection) produces mainly anxiogenic-like responses in various behavioural tasks. Based on findings that SP transmission is stimulated under stressful or anxiety-provoking situations it was hypothesised that blockade of NK1 receptors may attenuate stress responses and exert anxiolytic-like effects. Preclinical and clinical studies have found evidence in favour of such an assumption. The status of this research is reviewed here.

Keywords: Substance P – Tachykinin – Neurokinin – In vivo release – Anxiety – Depression – Antidepressant – Anxiolytic – Stress – HPA axis – NK1 receptor – NK1 receptor antagonist – Emotional behaviour – Microdialysis – Stress-related disorders 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adell, A 2004Antidepressant properties of substance P antagonists: relationship to monoaminergic mechanisms?Curr Drug Targets CNS Neurol Disord3113121PubMedGoogle Scholar
  2. Adell, A, Castro, E, Celada, P, Bortolozzi, A, Pazos, A, Artigas, F 2005Strategies for producing faster acting antidepressantsDrug Discov Today10578585PubMedGoogle Scholar
  3. Aguiar, MS, Brandao, ML 1994Conditioned place aversion produced by microinjections of substance P into the periaqueductal gray of ratsBehav Pharmacol5369373PubMedGoogle Scholar
  4. Aguiar, MS, Brandao, ML 1996Effects of microinjections of the neuropeptide substance P in the dorsal periaqueductal gray on the behaviour of rats in the plus-maze testPhysiol Behav6011831186PubMedGoogle Scholar
  5. Allen, BJ, Rogers, SD, Ghilardi, JR, Menning, PM, Kuskowski, MA, Basbaum, AI, Simone, DA, Mantyh, PW 1997Noxious cutaneous thermal stimuli induce a graded release of endogenous substance P in the spinal cord: imaging peptide action in vivoJ Neurosci1759215927PubMedGoogle Scholar
  6. Argyropoulos, SV, Sandford, JJ, Nutt, DJ 2000The psychobiology of anxiolytic drug. Part 2: Pharmacological treatments of anxietyPharmacol Ther88213227PubMedGoogle Scholar
  7. Ballard, TM, Sanger, S, Higgins, GA 2001Inhibition of shock-induced foot tapping behaviour in the gerbil by a tachykinin NK1 receptor antagonistEur J Pharmacol412255264PubMedGoogle Scholar
  8. Baretta, IP, Assreuy, J, De Lima, TC 2001Nitric oxide involvement in the anxiogenic-like effect of substance PBehav Brain Res121199205PubMedGoogle Scholar
  9. Baulmann, J, Spitznagel, H, Herdegen, T, Unger, T, Culman, J 2000Tachykinin receptor inhibition and c-Fos expression in the rat brain following formalin-induced painNeuroscience95813820PubMedGoogle Scholar
  10. Beresford, IJ, Birch, PJ, Hagan, RM, Ireland, SJ 1991Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96,345Br J Pharmacol104292293PubMedGoogle Scholar
  11. Bert, L, Rodier, D, Bougault, I, Allouard, N, Le-Fur, G, Soubrie, P, Steinberg, R 2002Permissive role of neurokinin NK(3) receptors in NK(1) receptor-mediated activation of the locus coeruleus revealed by SR 142801Synapse436269PubMedGoogle Scholar
  12. Bhatt, S, Gregg, TR, Siegel, A 2003NK1 receptors in the medial hypothalamus potentiate defensive rage behavior elicited from the midbrain periaqueductal gray of the catBrain Res9665464PubMedGoogle Scholar
  13. Bittencourt, JC, Benoit, R, Sawchenko, PE 1991Distribution and origins of substance P-immunoreactive projections to the paraventricular and supraoptic nuclei: partial overlap with ascending catecholaminergic projectionsJ Chem Neuroanat46378PubMedGoogle Scholar
  14. Bosker, FJ, Westerink, BH, Cremers, TI, Gerrits, M, van der Hart, MG, Kuipers, SD, van der Pompe, G, ter Horst, GJ, den Boer, JA, Korf, J 2004Future antidepressants: what is in the pipeline and what is missing?CNS Drugs18705732PubMedGoogle Scholar
  15. Boyce, S, Smith, D, Carlson, E, Hewson, L, Rigby, M, O’Donnell, R, Harrison, T, Rupniak, NM 2001Intra-amygdala injection of the substance P [NK(1) receptor] antagonist L-760735 inhibits neonatal vocalisations in guinea-pigsNeuropharmacology41130137PubMedGoogle Scholar
  16. Brodin, E, Lindefors, N, Ungerstedt, U 1983Potassium evoked in vivo release of substance P in rat caudate nucleus measured using a new technique of brain dialysis and an improved substance P-radioimmunoassayActa Physiol Scand Suppl5151720PubMedGoogle Scholar
  17. Brodin, E, Ogren, SO, Theodorsson-Norheim, E 1987Effects of subchronic treatment with imipramine, zimelidine and alaproclate on regional tissue levels of substance P- and neurokinin A/neurokinin B-like immunoreactivity in the brain and spinal cord of the ratNeuropharmacology26581590PubMedGoogle Scholar
  18. Brodin, E, Rosen, A, Schott, E, Brodin, K 1994aEffects of sequential removal of rats from a group cage, and of individual housing of rats, on substance P, cholecystokinin and somatostatin levels in the periaqueductal grey and limbic regionsNeuropeptides26253260Google Scholar
  19. Brodin, K, Ogren, SO, Brodin, E 1994bClomipramine and clonazepam increase cholecystokinin levels in rat ventral tegmental area and limbic regionsEur J Pharmacol263175180Google Scholar
  20. Brodin, K, Rosen, A, Iwarsson, K, Ogren, SO, Brodin, E 1989Increased levels of substance P and cholecystokinin in rat cerebral cortex following repeated electroconvulsive shock and subchronic treatment with a serotonin uptake inhibitorActa Physiol Scand136613614PubMedGoogle Scholar
  21. Burnet, PW, Miller, R, Lewis, LJ, Pei, Q, Sharp, T, Harrison, PJ 2001Electroconvulsive shock increases tachykinin NK(1) receptors, but not the encoding mRNA, in rat cortexEur J Pharmacol413213219PubMedGoogle Scholar
  22. Caberlotto, L, Hurd, YL, Murdock, P, Wahlin, JP, Melotto, S, Corsi, M, Carletti, R 2003Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brainEur J Neurosci1717361746PubMedGoogle Scholar
  23. Cheeseman, HJ, Pinnock, RD, Henderson, G 1983Substance P excitation of rat locus coeruleus neuronesEur J Pharmacol949399PubMedGoogle Scholar
  24. Cheeta, S, Tucci, S, Sandhu, J, Williams, AR, Rupniak, NM, File, SE 2001Anxiolytic actions of the substance P (NK1) receptor antagonist L-760735 and the 5-HT1A agonist 8-OH-DPAT in the social interaction test in gerbilsBrain Res915170175PubMedGoogle Scholar
  25. Chen, LW, Wei, LC, Liu, HL, Rao, ZR 2000Noradrenergic neurons expressing substance P receptor (NK1) in the locus coeruleus complex: a double immunofluorescence study in the ratBrain Res873155159PubMedGoogle Scholar
  26. Chowdrey, HS, Jessop, DS, Lightman, SL 1990Substance P stimulates arginine vasopressin and inhibits adrenocorticotropin release in vivo in the ratNeuroendocrinology529093PubMedGoogle Scholar
  27. Chowdrey, HS, Larsen, PJ, Harbuz, MS, Lightman, SL, Jessop, DS 1995Endogenous substance P inhibits the expression of corticotropin-releasing hormone during a chronic inflammatory stressLife Sci5720212029PubMedGoogle Scholar
  28. Commons, KG, Valentino, RJ 2002Cellular basis for the effects of substance P in the periaqueductal gray and dorsal raphe nucleusJ Comp Neurol4478297PubMedGoogle Scholar
  29. Conley, RK, Cumberbatch, MJ, Mason, GS, Williamson, DJ, Harrison, T, Locker, K, Swain, C, Maubach, K, O’Donnell, R, Rigby, M, Hewson, L, Smith, D, Rupniak, NM 2002Substance P (neurokinin 1) receptor antagonists enhance dorsal raphe neuronal activityJ Neurosci2277307736PubMedGoogle Scholar
  30. Culman, J, Unger, T 1995Central tachykinins: mediators of defence reaction and stress reactionsCan J Physiol Pharmacol73885891PubMedGoogle Scholar
  31. Culman, J, Klee, S, Ohlendorf, C, Unger, T 1997Effect of tachykinin receptor inhibition in the brain on cardiovascular and behavioral responses to stressJ Pharmacol Exp Ther280238246PubMedGoogle Scholar
  32. Czeh, B, Pudovkina, O, van der Hart, MG, Simon, M, Heilbronner, U, Michaelis, T, Watanabe, T, Frahm, J, Fuchs, E 2005aExamining SLV-323, a novel NK1 receptor antagonist, in a chronic psychosocial stress model for depressionPsychopharmacology180548557Google Scholar
  33. Czeh, B, Simon, M, van der Hart, MG, Schmelting, B, Hesselink, MB, Fuchs, E 2005bChronic stress decreases the number of parvalbumin-immunoreactive interneurons in the hippocampus: prevention by treatment with a substance P receptor (NK1) antagonistNeuropsychopharmacology306779Google Scholar
  34. Dableh, LJ, Yashpal, K, Rochford, J, Henry, JL 2005Antidepressant-like effects of neurokinin receptor antagonists in the forced swim test in the ratEur J Pharmacol50799105PubMedGoogle Scholar
  35. De Araujo, JE, Silva, RC, Huston, JP, Brandao, ML 1999Anxiogenic effects of substance P and its 7–11 C terminal, but not the 1–7 N terminal, injected into the dorsal periaqueductal grayPeptides2014371443PubMedGoogle Scholar
  36. De Araujo, JE, Huston, JP, Brandao, ML 2001aPlace aversion induced by microinjections of C-fragment of substance P into the dorsal periaqueductal gray of rats is mediated by tachykinin NK1 receptorsPeptides2214471452Google Scholar
  37. De Araujo, JE, Huston, JP, Brandao, ML 2001bOpposite effects of substance P fragments C (anxiogenic) and N (anxiolytic) injected into dorsal periaqueductal grayEur J Pharmacol4324351Google Scholar
  38. Dean, C, Marson, L, Kampine, JP 1993Distribution and co-localization of 5-hydroxytryptamine, thyrotropin-releasing hormone and substance P in the cat medullaNeuroscience57811822PubMedGoogle Scholar
  39. Ding, YQ, Shigemoto, R, Takada, M, Ohishi, H, Nakanishi, S, Mizuno, N 1996Localization of the neuromedin K receptor (NK3) in the central nervous system of the ratJ Comp Neurol364290310PubMedGoogle Scholar
  40. Duarte, FS, Testolin, R, De Lima, TC 2004Further evidence on the anxiogenic-like effect of substance P evaluated in the elevated plus-maze in ratsBehav Brain Res154501510PubMedGoogle Scholar
  41. Duffy, RA, Varty, GB, Morgan, CA, Lachowicz, JE 2002Correlation of neurokinin (NK) 1 receptor occupancy in gerbil striatum with behavioral effects of NK1 antagonistsJ Pharmacol Exp Ther301536542PubMedGoogle Scholar
  42. Duffy, RA, Hedrick, JA, Randolph, G, Morgan, CA, Cohen-Williams, ME, Vassileva, G, Lachowicz, JE, Laverty, M, Maguire, M, Shan, LS, Gustafson, E, Varty, GB 2003Centrally administered hemokinin-1 (HK-1), a neurokinin NK1 receptor agonist, produces substance P-like behavioral effects in mice and gerbilsNeuropharmacology45242250PubMedGoogle Scholar
  43. Duric, V, McCarson, KE 2005Hippocampal neurokinin-1 receptor and brain-derived neurotrophic factor gene expression is decreased in rat models of pain and stressNeuroscience1339991006PubMedGoogle Scholar
  44. Ebner, K, Rupniak, NM, Saria, A, Singewald, N 2004aSubstance P in the medial amygdala: emotional stress-sensitive release and modulation of anxiety-related behavior in ratsProc Natl Acad Sci USA10142804285Google Scholar
  45. Ebner, K, Saria, A, Singewald, N 2004bForced swim-induced release of substance P within the lateral septum modulates stress-coping behavior in ratsFENS ForumA127.6299Google Scholar
  46. Ebner, K, Singewald, N 2005Effects of NK1 receptor antagonist administration on basal and stress-induced substance P release in the amygdalaJ Neurochem94183Google Scholar
  47. Elliott, PJ 1988Place aversion induced by the substance P analogue, dimethyl-C7, is not state dependent: implication of substance P in aversionExp Brain Res73354356PubMedGoogle Scholar
  48. Faria, M, Navarra, P, Tsagarakis, S, Besser, GM, Grossman, AB 1991Inhibition of CRH-41 release by substance P, but not substance K, from the rat hypothalamus in vitroBrain Res5387678PubMedGoogle Scholar
  49. Fiebich, BL, Schleicher, S, Butcher, RD, Craig, A, Lieb, K 2000The neuropeptide substance P activates p38 mitogen-activated protein kinase resulting in IL-6 expression independently from NF-kappa BJ Immunol16556065611PubMedGoogle Scholar
  50. File, SE 1997Anxiolytic action of a neurokinin1 receptor antagonist in the social interaction testPharmacol Biochem Behav58747752PubMedGoogle Scholar
  51. File, SE 2000NKP608, an NK1 receptor antagonist, has an anxiolytic action in the social interaction test in ratsPsychopharmacology152105109PubMedGoogle Scholar
  52. Florin-Lechner, SM, Druhan, JP, Aston-Jones, G, Valentino, RJ 1996Enhanced norepinephrine release in prefrontal cortex with burst stimulation of the locus coeruleusBrain Res7428997PubMedGoogle Scholar
  53. Fong, TM, Yu, H, Strader, CD 1992Molecular basis for the species selectivity of the neurokinin-1 receptor antagonists CP-96,345 and RP67580J Biol Chem2672566825671PubMedGoogle Scholar
  54. Froger, N, Gardier, AM, Moratalla, R, Alberti, I, Lena, I, Boni, C, De Felipe, C, Rupniak, NM, Hunt, SP, Jacquot, C, Hamon, M, Lanfumey, L 20015-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitizationJ Neurosci2181888197PubMedGoogle Scholar
  55. Frommberger, UH, Bauer, J, Haselbauer, P, Fraulin, A, Riemann, D, Berger, M 1997Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remissionEur Arch Psychiatry Clin Neurosci247228233PubMedGoogle Scholar
  56. Furmark, T, Appel, L, Michelgard, A, Wahlstedt, K, Ahs, F, Zancan, S, Jacobsson, E, Flyckt, K, Grohp, M, Bergstrom, M, Pich, EM, Nilsson, LG, Bani, M, Langstrom, B, Fredrikson, M 2005Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placeboBiol Psychiatry58132142PubMedGoogle Scholar
  57. Gadd, CA, Murtra, P, De Felipe, C, Hunt, SP 2003Neurokinin-1 receptor-expressing neurons in the amygdala modulate morphine reward and anxiety behaviors in the mouseJ Neurosci2382718280PubMedGoogle Scholar
  58. Gall, C, Moore, RY 1984Distribution of enkephalin, substance P, tyrosine hydroxylase, and 5-hydroxytryptamine immunoreactivity in the septal region of the ratJ Comp Neurol225212227PubMedGoogle Scholar
  59. Garcia, M, Sakamoto, K, Shigekawa, M, Nakanishi, S, Ito, S 1994Multiple mechanisms of arachidonic acid release in Chinese hamster ovary cells transfected with cDNA of substance P receptorBiochem Pharmacol4817351741PubMedGoogle Scholar
  60. Gavioli, EC, Canteras, NS, De Lima, TC 1999Anxiogenic-like effect induced by substance P injected into the lateral septal nucleusNeuroreport1033993403PubMedGoogle Scholar
  61. Gavioli, EC, Canteras, NS, De Lima, TC 2002The role of lateral septal NK1 receptors in mediating anxiogenic effects induced by intracerebroventricular injection of substance PBehav Brain Res134411415PubMedGoogle Scholar
  62. Gentsch, C, Cutler, M, Vassout, A, Veenstra, S, Brugger, F 2002Anxiolytic effect of NKP608, a NK1-receptor antagonist, in the social investigation test in gerbilsBehav Brain Res133363368PubMedGoogle Scholar
  63. Gether, U, Johansen, TE, Snider, RM, Lowe, JA,3rd, Nakanishi, S, Schwartz, TW 1993Different binding epitopes on the NK1 receptor for substance P and non-peptide antagonistNature362345348PubMedGoogle Scholar
  64. Gobbi, G, Blier, P 2005Effect of neurokinin-1 receptor antagonists on serotoninergic, noradrenergic and hippocampal neurons: comparison with antidepressant drugsPeptides2613831393PubMedGoogle Scholar
  65. Gregg, TR, Siegel, A 2003Differential effects of NK1 receptors in the midbrain periaqueductal gray upon defensive rage and predatory attack in the catBrain Res9945566PubMedGoogle Scholar
  66. Guyenet, PG, Aghajanian, GK 1977Excitation of neurons in the nucleus locus coeruleus by substance P and related peptidesBrain Res136178184PubMedGoogle Scholar
  67. Haddjeri, N, Blier, P 2000Effect of neurokinin-I receptor antagonists on the function of 5-HT and noradrenaline neuronsNeuroreport1113231327PubMedCrossRefGoogle Scholar
  68. Haddjeri, N, Blier, P 2001Sustained blockade of neurokinin-1 receptors enhances serotonin neurotransmissionBiol Psychiatry50191199PubMedGoogle Scholar
  69. Hahn, MK, Bannon, MJ 1999Stress-induced C-fos expression in the rat locus coeruleus is dependent on neurokinin 1 receptor activationNeuroscience9411831188PubMedGoogle Scholar
  70. Halliday, GM, Li, YW, Joh, TH, Cotton, RG, Howe, PR, Geffen, LB, Blessing, WW 1988Distribution of substance P-like immunoreactive neurons in the human medulla oblongata: co-localization with monoamine-synthesizing neuronsSynapse2353370PubMedGoogle Scholar
  71. Hamon, M, Gozlan, H, Bourgoin, S, Benoliel, JJ, Mauborgne, A, Taquet, H, Cesselin, F, Mico, JA 1987Opioid receptors and neuropeptides in the CNS in rats treated chronically with amoxapine or amitriptylineNeuropharmacology26531539PubMedGoogle Scholar
  72. Hanley, M, Lee, C, Watson, S, Sandberg, B, Iversen, L 1981Biochemical and pharmacological studies of substance P receptorsProtides Biol Fluids29477482Google Scholar
  73. Harmar, AJ, Hyde, V, Chapman, K 1990Identification and cDNA sequence of delta-preprotachykinin, a fourth splicing variant of the rat substance P precursorFEBS Lett2752224PubMedGoogle Scholar
  74. Hasenöhrl, RU, Jentjens, O, De Souza Silva, MA, Tomaz, C, Huston, JP 1998Anxiolytic-like action of neurokinin substance P administered systemically or into the nucleus basalis magnocellularis regionEur J Pharmacol354123133PubMedGoogle Scholar
  75. Herkenham, M 1987Mismatches between neurotransmitter and receptor localizations in brain: observations and implicationsNeuroscience23138PubMedGoogle Scholar
  76. Herpfer, I, Hunt, SP, Stanford, SC 2005A comparison of neurokinin 1 receptor knock-out (NK1−/−) and wildtype mice: exploratory behaviour and extracellular noradrenaline concentration in the cerebral cortex of anaesthetised subjectsNeuropharmacology48706719PubMedGoogle Scholar
  77. Herpfer, I, Lieb, K 2005Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potentialCNS Drugs19275293PubMedGoogle Scholar
  78. Hökfelt, T, Kellerth, JO, Nilsson, G, Pernow, B 1975Substance P: localization in the central nervous system and in some primary sensory neuronsScience190889890PubMedGoogle Scholar
  79. Hökfelt, T, Vincent, S, Dalsgaard, CJ, Skirboll, L, Johansson, O, Schultzberg, M, Lundberg, JM, Rosell, S, Pernow, B, Jancso, G 1982Distribution of substance P in brain and periphery and its possible role as a co-transmitterCiba Found Symp9184106PubMedGoogle Scholar
  80. Hökfelt, T, Broberger, C, Xu, ZQ, Sergeyev, V, Ubink, R, Diez, M 2000Neuropeptides – an overviewNeuropharmacology3913371356PubMedGoogle Scholar
  81. Holsboer, F, Barden, N 1996Antidepressants and hypothalamic-pituitary-adrenocortical regulationEndocr Rev17187205PubMedGoogle Scholar
  82. Hong, JS, Tilson, HA, Yoshikawa, K 1983Effects of lithium and haloperidol administration on the rat brain levels of substance PJ Pharmacol Exp Ther224590593PubMedGoogle Scholar
  83. Husum, H, Vasquez, PA, Mathé, AA 2001Changed concentrations of tachykinins and neuropeptide Y in brain of a rat model of depression: lithium treatment normalizes tachykininsNeuropsychopharmacology24183191PubMedGoogle Scholar
  84. Hwang, BH, Katner, J, Iyengar, S 2005Corticotropin-releasing factor mRNA and substance P receptor binding in the paraventricular hypothalamic nucleus, central nucleus of the amygdala, and locus coeruleus of Sprague-Dawley rats following restraint-induced stressJ Mol Neurosci25239250PubMedGoogle Scholar
  85. Igwe, OJ, Kim, DC, Seybold, VS, Larson, AA 1990Specific binding of substance P aminoterminal heptapeptide [SP(1–7)] to mouse brain and spinal cord membranesJ Neurosci1036533663PubMedGoogle Scholar
  86. Ikeda, K, Miyata, K, Orita, A, Kubota, H, Yamada, T, Tomioka, K 1995RP67580, a neurokinin1 receptor antagonist, decreased restraint stress-induced defecation in ratNeurosci Lett198103106PubMedGoogle Scholar
  87. Jarry, H, Perschl, A, Meissner, H, Wuttke, W 1988In vivo release rates of substance P in the preoptic/anterior hypothalamic area of ovariectomized and ovariectomized estrogen-primed rats: correlation with luteinizing hormone and prolactin levelsNeurosci Lett88189194PubMedGoogle Scholar
  88. Jessell, TM 1978Substance P release from the rat substantia nigraBrain Res151469478PubMedGoogle Scholar
  89. Jessop, DS, Renshaw, D, Larsen, PJ, Chowdrey, HS, Harbuz, MS 2000Substance P is involved in terminating the hypothalamo-pituitary-adrenal axis response to acute stress through centrally located neurokinin-1 receptorsStress3209220PubMedGoogle Scholar
  90. Jones, MT, Gillham, B, Holmes, MC, Hodges, JR, Buckingham, JC 1978Influence of substance P on hypothalamo-pituitary-adrenocorticol activity in the ratJ Endocrinol76183184PubMedGoogle Scholar
  91. Jones, RS, Mondadori, C, Olpe, HR 1985Neuronal sensitivity to substance P is increased after repeated treatment with tranylcypromine, carbamazepine or oxaprotaline, but decreased after repeated electroconvulsive shockNeuropharmacology24627633PubMedGoogle Scholar
  92. Kachidian, P, Poulat, P, Marlier, L, Privat, A 1991Immunohistochemical evidence for the coexistence of substance P, thyrotropin-releasing hormone, GABA, methionine-enkephalin, and leucin-enkephalin in the serotonergic neurons of the caudal raphe nuclei: a dual labeling in the ratJ Neurosci Res30521530PubMedGoogle Scholar
  93. Kang, TC, Seo, J, Jeon, GS, Shin, DH, Kim, YW, Lim, HS, Lee, KH, Hwang, DH, Won, MH, Cho, SS 1999Are substance P neurons of the paraventricular nucleus related to the osmotic regulation in the Mongolian gerbil?Brain Res820101104PubMedGoogle Scholar
  94. Kawano, H, Masuko, S 1995Substance P innervation of neurons projecting to the paraventricular hypothalamic nucleus in the rat nucleus tractus solitariusBrain Res689136140PubMedGoogle Scholar
  95. Keck, ME, Welt, T, Muller, MB, Uhr, M, Ohl, F, Wigger, A, Toschi, N, Holsboer, F, Landgraf, R 2003Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevant behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat modelNeuropsychopharmacology28235243PubMedGoogle Scholar
  96. Keller, M, Montgomery, S, Ball, W, Morrison, M, Snavely, D, Liu, G, Hargreaves, R, Hietala, J, Lines, C, Beebe, K, Reines, S 2006Lack of efficacy of the substance p (neurokinin(1) receptor) antagonist aprepitant in the treatment of major depressive disorderBiol Psychiatry59216223PubMedGoogle Scholar
  97. Kendrick, KM 1990Microdialysis measurement of in vivo neuropeptide releaseJ Neurosci Methods343546PubMedGoogle Scholar
  98. Khawaja, AM, Rogers, DF 1996Tachykinins: receptor to effectorInt J Biochem Cell Biol28721738PubMedGoogle Scholar
  99. Kohler, C, Chan-Palay, V, Steinbusch, H 1982The distribution and origin of serotonin-containing fibers in the septal area: a combined immunohistochemical and fluorescent retrograde tracing study in the ratJ Comp Neurol20991111PubMedGoogle Scholar
  100. Koshiya, K, Kato, T 1983Acute changes in nigral substance P content induced by drugs acting on dopamine, muscarine and GABA receptorsNaunyn Schmiedebergs Arch Pharmacol324223227PubMedGoogle Scholar
  101. Kotani, H, Hoshimaru, M, Nawa, H, Nakanishi, S 1986Structure and gene organization of bovine neuromedin K precursorProc Natl Acad Sci USA8370747078PubMedGoogle Scholar
  102. Kramer, MS, Cutler, N, Feighner, J, Shrivastava, R, Carman, J, Sramek, JJ, Reines, SA, Liu, G, Snavely, D, Wyatt-Knowles, E, Hale, JJ, Mills, SG, MacCoss, M, Swain, CJ, Harrison, T, Hill, RG, Hefti, F, Scolnick, EM, Cascieri, MA, Chicchi, GG, Sadowski, S, Williams, AR, Hewson, L, Smith, D, Carlson, EJ, Hargreaves, RJ, Rupniak, NM 1998Distinct mechanism for antidepressant activity by blockade of central substance P receptorsScience28116401645PubMedGoogle Scholar
  103. Kramer, MS, Winokur, A, Kelsey, J, Preskorn, SH, Rothschild, AJ, Snavely, D, Ghosh, K, Ball, WA, Reines, SA, Munjack, D, Apter, JT, Cunningham, L, Kling, M, Bari, M, Getson, A, Lee, Y 2004Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depressionNeuropsychopharmacology29385392PubMedGoogle Scholar
  104. Krase, W, Koch, M, Schnitzler, HU 1994Substance P is involved in the sensitization of the acoustic startle response by footshocks in ratsBehav Brain Res638188PubMedGoogle Scholar
  105. Kuang, P, Lang, S, Liu, J, Zhang, F, Wu, W 1991The investigation of antiepileptic action of qingyangshen (QYS) – effect of QYS on the concentrations of neuropeptides in rat brainJ Trad Chin Med114046Google Scholar
  106. Landgraf, R, Neumann, ID 2004Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communicationFront Neuroendocrinol25150176PubMedGoogle Scholar
  107. Landgraf, R, Wigger, A 2002High vs low anxiety-related behavior rats: an animal model of extremes in trait anxietyBehav Genet32301314PubMedGoogle Scholar
  108. Landgraf, R, Wigger, A 2003Born to be anxious: neuroendocrine and genetic correlates of trait anxiety in HAB ratsStress6111119PubMedCrossRefGoogle Scholar
  109. Larsen, PJ 1992Distribution of substance P-immunoreactive elements in the preoptic area and the hypothalamus of the ratJ Comp Neurol316287313PubMedGoogle Scholar
  110. Larsen, PJ, Jessop, D, Patel, H, Lightman, SL, Chowdrey, HS 1993Substance P inhibits the release of anterior pituitary adrenocorticotrophin via a central mechanism involving corticotrophin-releasing factor-containing neurons in the hypothalamic paraventricular nucleusJ Neuroendocrinol599105PubMedGoogle Scholar
  111. Leger, L, Charnay, Y, Hof, PR, Bouras, C, Cespuglio, R 2001Anatomical distribution of serotonin-containing neurons and axons in the central nervous system of the catJ Comp Neurol433157182PubMedGoogle Scholar
  112. Lenard, L, Kertes, E 2002Influence of passive avoidance learning by substance P in the basolateral amygdalaActa Biol Hung5395104PubMedGoogle Scholar
  113. Lieb, K, Fiebich, BL, Berger, M, Bauer, J, Schulze-Osthoff, K 1997The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cellsJ Immunol15949524958PubMedGoogle Scholar
  114. Lieb, K, Treffurth, Y, Hamke, M, Akundi, RS, von Kleinsorgen, M, Fiebich, BL 2003Valproic acid inhibits substance P-induced activation of protein kinase C epsilon and expression of the substance P receptorJ Neurochem866976PubMedGoogle Scholar
  115. Lindefors, N, Brodin, E, Theodorsson-Norheim, E, Ungerstedt, U 1985Regional distribution and in vivo release of tachykinin-like immunoreactivities in rat brain: evidence for regional differences in relative proportions of tachykininsRegul Pept10217230PubMedGoogle Scholar
  116. Lindefors, N, Yamamoto, Y, Pantaleo, T, Lagercrantz, H, Brodin, E, Ungerstedt, U 1986In vivo release of substance P in the nucleus tractus solitarii increases during hypoxiaNeurosci Lett699497PubMedGoogle Scholar
  117. Lindefors, N, Brodin, E, Ungerstedt, U 1987Microdialysis combined with a sensitive radioimmunoassay. A technique for studying in vivo release of neuropeptidesJ Pharmacol Methods17305312PubMedGoogle Scholar
  118. Lindefors, N, Brodin, E, Ungerstedt, U 1989aSubchronic haloperidol treatment decreases the in vivo release of tachykinins in rat substantia nigraEur J Pharmacol1619598Google Scholar
  119. Lindefors, N, Brodin, E, Tossman, U, Segovia, J, Ungerstedt, U 1989bTissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervationExp Brain Res74527534Google Scholar
  120. Lindefors, N, Brodin, K, Stiller, CO, Persson, H, Brodin, E 1991Repeated electroconvulsive shock increases tachykinin and cholecystokinin mRNA expression in ventral periaqueductal grayNeuroscience457380PubMedGoogle Scholar
  121. Lisoprawski, A, Blanc, G, Glowinski, J 1981Activation by stress of the habenulo-interpeduncular substance P neurons in the ratNeurosci Lett254751PubMedGoogle Scholar
  122. Liu, R, Ding, Y, Aghajanian, GK 2002Neurokinins activate local glutamatergic inputs to serotonergic neurons of the dorsal raphe nucleusNeuropsychopharmacology27329340PubMedGoogle Scholar
  123. Ljungdahl, A, Hökfelt, T, Nilsson, G 1978Distribution of substance P-like immunoreactivity in the central nervous system of the rat I. Cell bodies and nerve terminalsNeuroscience3861943PubMedGoogle Scholar
  124. Loiseau, F, Le Bihan, C, Hamon, M, Thiebot, MH 2003Distinct effects of diazepam and NK1 receptor antagonists in two conflict procedures in ratsBehav Pharmacol14447455PubMedGoogle Scholar
  125. Loiseau, F, Le Bihan, C, Hamon, M, Thiebot, MH 2005Antidepressant-like effects of agomelatine, melatonin and the NK1 receptor antagonist GR205171 in impulsive-related behaviour in ratsPsychopharmacology1822432PubMedGoogle Scholar
  126. Lucas, LR, Pompei, P, McEwen, BS 1997Effects of deoxycorticosterone acetate and diazepam on neuropeptidergic neurons in rat striatumNeuroreport8811816PubMedGoogle Scholar
  127. Ma, QP, Bleasdale, C 2002Modulation of brain stem monoamines and gamma-aminobutyric acid by NK1 receptors in ratsNeuroreport1318091812PubMedGoogle Scholar
  128. Maeno, H, Kiyama, H, Tohyama, M 1993Distribution of the substance P receptor (NK-1 receptor) in the central nervous systemBrain Res Mol Brain Res184358PubMedGoogle Scholar
  129. Maes, M, Meltzer, HY, Bosmans, E, Bergmans, R, Vandoolaeghe, E, Ranjan, R, Desnyder, R 1995Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depressionJ Affect Disord34301309PubMedGoogle Scholar
  130. Maggi, CA 1995The mammalian tachykinin receptorsGen Pharmacol26911944PubMedGoogle Scholar
  131. Maggi, CA, Schwartz, TW 1997The dual nature of the tachykinin NK1 receptorTrends Pharmacol Sci18351355PubMedGoogle Scholar
  132. Malcangio, M, Bowery, NG 1999Peptide autoreceptors: does an autoreceptor for substance P exist?Trends Pharmacol Sci20405407PubMedGoogle Scholar
  133. Mantyh, PW, Hunt, SP, Maggio, JE 1984Substance P receptors: localization by light microscopic autoradiography in rat brain using SP as the radioligandBrain Res307147165PubMedGoogle Scholar
  134. Mantyh, PW, Gates, T, Mantyh, CR, Maggio, JE 1989Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissuesJ Neurosci9258279PubMedGoogle Scholar
  135. Mantyh, PW, Allen, CJ, Ghilardi, JR, Rogers, SD, Mantyh, CR, Liu, H, Basbaum, AI, Vigna, SR, Maggio, JE 1995Rapid endocytosis of a G protein-coupled receptor: substance P evoked internalization of its receptor in the rat striatum in vivoProc Natl Acad Sci USA9226222626PubMedGoogle Scholar
  136. Mathé, AA, Jousisto-Hanson, J, Stenfors, C, Theodorsson, E 1990Effect of lithium on tachykinins, calcitonin gene-related peptide, and neuropeptide Y in rat brainJ Neurosci Res26233237PubMedGoogle Scholar
  137. Mathé, AA, Wikner, BN, Stenfors, C, Theodorsson, E 1994Effects of lithium on neuropeptide Y, neurokinin A and substance P in brain and peripheral tissues of ratLithium5241247Google Scholar
  138. Maubach, KA, Martin, K, Chicchi, G, Harrison, T, Wheeldon, A, Swain, CJ, Cumberbatch, MJ, Rupniak, NM, Seabrook, GR 2002Chronic substance P (NK1) receptor antagonist and conventional antidepressant treatment increases burst firing of monoamine neurones in the locus coeruleusNeuroscience109609617PubMedGoogle Scholar
  139. McLean, S 2005Do substance P and the NK1 receptor have a role in depression and anxiety?Curr Pharm Des1115291547PubMedGoogle Scholar
  140. Michael-Titus, AT, Blackburn, D, Connolly, Y, Priestley, JV, Whelpton, R 1999N- and C-terminal substance P fragments: differential effects on striatal substance P binding and NK1 receptor internalizationNeuroreport1022092213PubMedGoogle Scholar
  141. Michelot, R, Leviel, V, Torrens, Y, Glowinski, J, Cheramy, A 1979In vivo release of substance P in the cat substantia nigraNeurosci Lett15141146PubMedGoogle Scholar
  142. Millan, MJ, Lejeune, F, De Nanteuil, G, Gobert, A 2001Selective blockade of neurokinin (NK)(1) receptors facilitates the activity of adrenergic pathways projecting to frontal cortex and dorsal hippocampus in ratsJ Neurochem7619491954PubMedGoogle Scholar
  143. Mitsuhashi, M, Ohashi, Y, Shichijo, S, Christian, C, Sudduth-Klinger, J, Harrowe, G, Payan, DG 1992Multiple intracellular signaling pathways of the neuropeptide substance P receptorJ Neurosci Res32437443PubMedGoogle Scholar
  144. Mitsushio, H, Takashima, M, Mataga, N, Toru, M 1988Effects of chronic treatment with trihexyphenidyl and carbamazepine alone or in combination with haloperidol on substance P content in rat brain: a possible implication of substance P in affective disordersJ Pharmacol Exp Ther245982989PubMedGoogle Scholar
  145. Mochizuki-Oda, N, Nakajima, Y, Nakanishi, S, Ito, S 1994Characterization of the substance P receptor-mediated calcium influx in cDNA transfected Chinese hamster ovary cells. A possible role of inositol 1,4,5-trisphosphate in calcium influxJ Biol Chem26996519658PubMedGoogle Scholar
  146. Molewijk, HE, Hartog, K, van der Poel, AM, Mos, J, Olivier, B 1996Reduction of guinea pig pup isolation calls by anxiolytic and antidepressant drugsPsychopharmacology1283138PubMedGoogle Scholar
  147. Morilak, DA, Morris, M, Chalmers, J 1988Release of substance P in the nucleus tractus solitarius measured by in vivo microdialysis: response to stimulation of the aortic depressor nerves in rabbitNeurosci Lett94131137PubMedGoogle Scholar
  148. Muigg P, Sartori SB, Sparber T, Landgraf R, Singewald N (2005) Reduced depression-like behaviour in HAB rats after NK1-receptor antagonist treatment is associated with an altered neuronal activation pattern in specific brain areas. Abstract at the Meeting of the Austrian Neuroscience AssociationGoogle Scholar
  149. Nagashima, A, Takano, Y, Masui, H, Kamiya, H 1987Evidence that neurokinin A (substance K) neurons project from the striatum to the substantia nigra in ratsNeurosci Lett77103108PubMedGoogle Scholar
  150. Nakajima, Y, Tsuchida, K, Negishi, M, Ito, S, Nakanishi, S 1992Direct linkage of three tachykinin receptors to stimulation of both phosphatidylinositol hydrolysis and cyclic AMP cascades in transfected Chinese hamster ovary cellsJ Biol Chem26724372442PubMedGoogle Scholar
  151. Nakamura, H, Moroji, T, Nohara, S, Nakamura, H, Okada, A 1990Effects of whole-body vibration stress on substance P- and neurotensin-like immunoreactivity in the rat brainEnviron Res52155163PubMedGoogle Scholar
  152. Nakanishi, S 1991Mammalian tachykinin receptorsAnnu Rev Neurosci14123136PubMedGoogle Scholar
  153. Nakanishi, S, Nakajima, Y, Yokota, Y 1993Signal transduction and ligand-binding domains of the tachykinin receptorsRegul Pept463742PubMedGoogle Scholar
  154. Nakaya, Y, Kaneko, T, Shigemoto, R, Nakanishi, S, Mizuno, N 1994Immunohistochemical localization of substance P receptor in the central nervous system of the adult ratJ Comp Neurol347249274PubMedGoogle Scholar
  155. Nawa, H, Hirose, T, Takashima, H, Inayama, S, Nakanishi, S 1983Nucleotide sequences of cloned cDNAs for two types of bovine brain substance P precursorNature3063236PubMedGoogle Scholar
  156. Nawa, H, Kotani, H, Nakanishi, S 1984Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicingNature312729734PubMedGoogle Scholar
  157. Nemeroff, CB 2003Anxiolytics: past, present, and future agentsJ Clin Psychiatry6436PubMedGoogle Scholar
  158. Neumann, ID, Kromer, SA, Toschi, N, Ebner, K 2000Brain oxytocin inhibits the (re)activity of the hypothalamo-pituitary-adrenal axis in male rats: involvement of hypothalamic and limbic brain regionsRegul Pept963138PubMedGoogle Scholar
  159. Nicholas, AP, Pieribone, VA, Arvidsson, U, Hökfelt, T 1992Serotonin-, substance P- and glutamate/aspartate-like immunoreactivities in medullo-spinal pathways of rat and primateNeuroscience48545559PubMedGoogle Scholar
  160. Nikolaus, S, Huston, JP, Hasenöhrl, RU 1999aThe neurokinin-1 receptor antagonist WIN51,708 attenuates the anxiolytic-like effects of ventralpallidal substance P injectionNeuroreport1022932296Google Scholar
  161. Nikolaus, S, Huston, JP, Hasenöhrl, RU 1999bReinforcing effects of neurokinin substance P in the ventral pallidum: mediation by the tachykinin NK1 receptorEur J Pharmacol3709399Google Scholar
  162. Nikolaus, S, Huston, JP, Hasenöhrl, RU 2000Anxiolytic-like effects in rats produced by ventral pallidal injection of both N- and C-terminal fragments of substance PNeurosci Lett2833740PubMedGoogle Scholar
  163. Oblin, A, Zivkovic, B, Bartholini, G 1984Involvement of the D-2 dopamine receptor in the neuroleptic-induced decrease in nigral substance PEur J Pharmacol105175177PubMedGoogle Scholar
  164. Orosz, D, Bennett, JP,Jr 1990Baseline and apomorphine-induced extracellular levels of nigral substance P are increased in an animal model of Parkinson’s diseaseEur J Pharmacol182509514PubMedGoogle Scholar
  165. Otsuka, M, Yoshioka, K 1993Neurotransmitter functions of mammalian tachykininsPhysiol Rev73229308PubMedGoogle Scholar
  166. Page, NM 2004Hemokinins and endokininsCell Mol Life Sci6116521663PubMedGoogle Scholar
  167. Papp, M, Vassout, A, Gentsch, C 2000The NK1-receptor antagonist NKP608 has an antidepressant-like effect in the chronic mild stress model of depression in ratsBehav Brain Res1151923PubMedGoogle Scholar
  168. Pernow, B 1983Substance PPharmacol Rev3585141PubMedGoogle Scholar
  169. Pickel, VM, Joh, TH, Reis, DJ, Leeman, SE, Miller, RJ 1979Electron microscopic localization of substance P and enkephalin in axon terminals related to dendrites of catecholaminergic neuronsBrain Res160387400PubMedGoogle Scholar
  170. Potts, JT, Fuchs, IE, Li, J, Leshnower, B, Mitchell, JH 1999Skeletal muscle afferent fibres release substance P in the nucleus tractus solitarii of anaesthetized catsJ Physiol514829841PubMedGoogle Scholar
  171. Potts, JT, Fuchs, IE 2001Naturalistic activation of barosensitive afferents release substance P in the nucleus tractus solitarius of the catBrain Res893155164PubMedGoogle Scholar
  172. Quartara, L, Maggi, CA 1997The tachykinin NK1 receptor. Part I: ligands and mechanisms of cellular activationNeuropeptides31537563PubMedGoogle Scholar
  173. Quartara, L, Maggi, CA 1998The tachykinin NK1 receptor. Part II: Distribution and pathophysiological rolesNeuropeptides32149PubMedGoogle Scholar
  174. Regoli, D, Boudon, A, Fauchere, JL 1994Receptors and antagonists for substance P and related peptidesPharmacol Rev46551599PubMedGoogle Scholar
  175. Ribeiro-da-Silva, A, Hökfelt, T 2000Neuroanatomical localisation of substance P in the CNS and sensory neuronsNeuropeptides34256271PubMedGoogle Scholar
  176. Ribeiro, RL, De Lima, TC 2002Participation of GABAA receptors in the modulation of experimental anxiety by tachykinin agonists and antagonists in miceProg Neuropsychopharmacol Biol Psychiatry26861869PubMedGoogle Scholar
  177. Riley, LA, Hart, RP, Jonakait, GM 1991Both zimelidine and clorgyline decrease preprotachykinin mRNA in adult medullary raphe nucleiMol Cell Neurosci2139144PubMedGoogle Scholar
  178. Roberts, GW, Woodhams, PL, Polak, JM, Crow, TJ 1982Distribution of neuropeptides in the limbic system of the rat: the amygdaloid complexNeuroscience799131PubMedGoogle Scholar
  179. Rodgers, RJ, Gentsch, C, Hoyer, D, Bryant, E, Green, AJ, Kolokotroni, KZ, Martin, JL 2004The NK1 receptor antagonist NKP608 lacks anxiolytic-like activity in Swiss-Webster mice exposed to the elevated plus-mazeBehav Brain Res154183192PubMedCrossRefGoogle Scholar
  180. Rogers SD, Salak-Johnson JL, Schwei MJ, Pomonis JD, Mantyh PW (2000) Reduced anxiety related behavior following ablation of amygdala neurons expressing substance P receptor. Soc Neurosci AbstrGoogle Scholar
  181. Rosen, A, Brodin, K, Eneroth, P, Brodin, E 1992Short-term restraint stress and s.c. saline injection alter the tissue levels of substance P and cholecystokinin in the periaqueductal grey and limbic regions of rat brainActa Physiol Scand146341348PubMedCrossRefGoogle Scholar
  182. Rosen, A, Franck, J, Brodin, E 1995Effects of acute systemic treatment with the 5 HT-uptake blocker alaproclate on tissue levels and release of substance P in rat periaqueductal greyNeuropeptides28317324PubMedGoogle Scholar
  183. Rosen, A, Zhang, YX, Lund, I, Lundeberg, T, Yu, LC 2004Substance P microinjected into the periaqueductal gray matter induces antinociception and is released following morphine administrationBrain Res10018794PubMedGoogle Scholar
  184. Rupniak, NM 2002New insights into the antidepressant actions of substance P (NK1 receptor) antagonistsCan J Physiol Pharmacol80489494PubMedGoogle Scholar
  185. Rupniak, NM, Boyce, S, Williams, AR, Cook, G, Longmore, J, Seabrook, GR, Caeser, M, Iversen, SD, Hill, RG 1993Antinociceptive activity of NK1 receptor antagonists: non-specific effects of racemic RP67580Br J Pharmacol11016071613PubMedGoogle Scholar
  186. Rupniak, NM, Williams, AR 1994Differential inhibition of foot tapping and chromodacryorrhoea in gerbils by central nervous system penetrant and non-penetrant tachykinin NK1 receptor antagonistsEur J Pharmacol265179183PubMedGoogle Scholar
  187. Rupniak, NM, Carlson, EC, Harrison, T, Oates, B, Seward, E, Owen, S, de Felipe, C, Hunt, S, Wheeldon, A 2000Pharmacological blockade or genetic deletion of substance P (NK1) receptors attenuates neonatal vocalisation in guinea-pigs and miceNeuropharmacology3914131421PubMedGoogle Scholar
  188. Rupniak, NM, Carlson, EJ, Webb, JK, Harrison, T, Porsolt, RD, Roux, S, de Felipe, C, Hunt, SP, Oates, B, Wheeldon, A 2001Comparison of the phenotype of NK1R−/− mice with pharmacological blockade of the substance P (NK1) receptor in assays for antidepressant and anxiolytic drugsBehav Pharmacol12497508PubMedGoogle Scholar
  189. Rupniak, NM, Webb, JK, Fisher, A, Smith, D, Boyce, S 2003aThe substance P (NK1) receptor antagonist L-760735 inhibits fear conditioning in gerbilsNeuropharmacology44516523Google Scholar
  190. Rupniak, NM, Carlson, EJ, Shepheard, S, Bentley, G, Williams, AR, Hill, A, Swain, C, Mills, SG, Di Salvo, J, Kilburn, R, Cascieri, MA, Kurtz, MM, Tsao, KL, Gould, SL, Chicchi, GG 2003bComparison of the functional blockade of rat substance P (NK1) receptors by GR205171, RP67580, SR140333 and NKP-608Neuropharmacology45231241Google Scholar
  191. Ryckmans, T, Balancon, L, Berton, O, Genicot, C, Lamberty, Y, Lallemand, B, Pasau, P, Pirlot, N, Quere, L, Talaga, P 2002aFirst dual NK(1) antagonists-serotonin reuptake inhibitors: synthesis and SAR of a new class of potential antidepressantsBioorg Med Chem Lett12261264Google Scholar
  192. Ryckmans, T, Berton, O, Grimee, R, Kogej, T, Lamberty, Y, Pasau, P, Talaga, P, Genicot, C 2002bDual NK(1) antagonists – serotonin reuptake inhibitors as potential antidepressants. Part 2: SAR and activity of benzyloxyphenethyl piperazine derivativesBioorg Med Chem Lett1231953198Google Scholar
  193. Sachais, BS, Snider, RM, Lowe, JA,3rd, Krause, JE 1993Molecular basis for the species selectivity of the substance P antagonist CP-96,345J Biol Chem26823192323PubMedGoogle Scholar
  194. Saffroy, M, Beaujouan, JC, Torrens, Y, Besseyre, J, Bergstrom, L, Glowinski, J 1988Localization of tachykinin binding sites (NK1, NK2, NK3 ligands) in the rat brainPeptides9227241PubMedGoogle Scholar
  195. Saffroy, M, Beaujouan, JC, Petitet, F, Torrens, Y, Glowinski, J 1994Differential localization of 3H-[Pro9]SP binding sites in the guinea pig and rat brainBrain Res633317325PubMedGoogle Scholar
  196. Saffroy, M, Torrens, Y, Glowinski, J, Beaujouan, JC 2003Autoradiographic distribution of tachykinin NK2 binding sites in the rat brain: comparison with NK1 and NK3 binding sitesNeuroscience116761773PubMedGoogle Scholar
  197. Saleh, TM 1997Visceral afferent stimulation-evoked changes in the release of peptides into the parabrachial nucleus in vivoBrain Res7785663PubMedGoogle Scholar
  198. Santarelli, L, Gobbi, G, Debs, PC, Sibille, ET, Blier, P, Hen, R, Heath, MJ 2001Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic functionProc Natl Acad Sci USA9819121917PubMedGoogle Scholar
  199. Santarelli, L, Gobbi, G, Blier, P, Hen, R 2002Behavioral and physiologic effects of genetic or pharmacologic inactivation of the substance P receptor (NK1)J Clin Psychiatry631117PubMedGoogle Scholar
  200. Saria, A 1999The tachykinin NK1 receptor in the brain: pharmacology and putative functionsEur J Pharmacol3755160PubMedGoogle Scholar
  201. Sartori, SB, Burnet, PW, Sharp, T, Singewald, N 2004Evaluation of the effect of chronic antidepressant treatment on neurokinin-1 receptor expression in the rat brainNeuropharmacology4611771183PubMedGoogle Scholar
  202. Sartori, SB, Ebner, K, Muigg, P, Landgraf, R, Singewald, N 2005Differences in substance P neurotransmission between rats with high vs. low trait anxiety/depressionJ Neurochem94229Google Scholar
  203. Seabrook, GR, Fong, TM 1993Thapsigargin blocks the mobilisation of intracellular calcium caused by activation of human NK1 (long) receptors expressed in Chinese hamster ovary cellsNeurosci Lett152912PubMedGoogle Scholar
  204. Sekizawa, S, Joad, JP, Bonham, AC 2003Substance P presynaptically depresses the transmission of sensory input to bronchopulmonary neurons in the guinea pig nucleus tractus solitariiJ Physiol552547559PubMedGoogle Scholar
  205. Sergeyev, V, Fetissov, S, Mathe, AA, Jimenez, PA, Bartfai, T, Mortas, P, Gaudet, L, Moreau, JL, Hökfelt, T 2005Neuropeptide expression in rats exposed to chronic mild stressesPsychopharmacology178115124PubMedGoogle Scholar
  206. Severini, C, Improta, G, Falconieri-Erspamer, G, Salvadori, S, Erspamer, V 2002The tachykinin peptide familyPharmacol Rev54285322PubMedGoogle Scholar
  207. Shirayama, Y, Mitsushio, H, Takashima, M, Ichikawa, H, Takahashi, K 1996Reduction of substance P after chronic antidepressants treatment in the striatum, substantia nigra and amygdala of the ratBrain Res7397078PubMedGoogle Scholar
  208. Shults, CW, Quirion, R, Jensen, RT, Moody, TW, O’Donohue, TL, Chase, TN 1982Autoradiographic localization of substance P receptors using 125I substance PPeptides310731075PubMedGoogle Scholar
  209. Shults, CW, Quirion, R, Chronwall, B, Chase, TN, O’Donohue, TL 1984A comparison of the anatomical distribution of substance P and substance P receptors in the rat central nervous systemPeptides510971128PubMedGoogle Scholar
  210. Siegel, RA, Duker, EM, Fuchs, E, Pahnke, U, Wuttke, W 1984Responsiveness of mesolimbic, mesocortical, septal and hippocampal cholecystokinin and substance P neuronal systems to stress, in the male ratNeurochem Int6783789PubMedGoogle Scholar
  211. Siegel, RA, Duker, EM, Pahnke, U, Wuttke, W 1987Stress-induced changes in cholecystokinin and substance P concentrations in discrete regions of the rat hypothalamusNeuroendocrinology467581PubMedGoogle Scholar
  212. Singewald, N, Kaehler, ST, Philippu, A 1999Noradrenaline release in the locus coeruleus of conscious rats is triggered by drugs, stress and blood pressure changesNeuroreport1015831587PubMedGoogle Scholar
  213. Sivam, SP, Krause, JE, Takeuchi, K, Li, S, McGinty, JF, Hong, JS 1989Lithium increases rat striatal beta- and gamma-preprotachykinin messenger RNAsJ Pharmacol Exp Ther24812971301PubMedGoogle Scholar
  214. Smith, DW, Hewson, L, Fuller, P, Williams, AR, Wheeldon, A, Rupniak, NM 1999The substance P antagonist L-760,735 inhibits stress-induced NK(1) receptor internalisation in the basolateral amygdalaBrain Res8489095PubMedGoogle Scholar
  215. Snider, RM, Constantine, JW, Lowe, JA,3rd, Longo, KP, Lebel, WS, Woody, HA, Drozda, SE, Desai, MC, Vinick, FJ, Spencer, RW,  et al. 1991A potent nonpeptide antagonist of the substance P (NK1) receptorScience251435437PubMedGoogle Scholar
  216. Spooren, WP, Schoeffter, P, Gasparini, F, Kuhn, R, Gentsch, C 2002Pharmacological and endocrinological characterisation of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608)Eur J Pharmacol435161170PubMedGoogle Scholar
  217. Srinivasan, M, Goiny, M, Pantaleo, T, Lagercrantz, H, Brodin, E, Runold, M, Yamamoto, Y 1991Enhanced in vivo release of substance P in the nucleus tractus solitarii during hypoxia in the rabbit: role of peripheral inputBrain Res546211216PubMedGoogle Scholar
  218. Steinberg, R, Alonso, R, Rouquier, L, Desvignes, C, Michaud, JC, Cudennec, A, Jung, M, Simiand, J, Griebel, G, Emonds-Alt, X, Le Fur, G, Soubrie, P 2002SSR240600 (R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl acetyl]-2-(3,4-dichloro phenyl)-2-morpholinyl]ethyl]-4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin 1 receptor: II. Neurochemical and behavioral characterizationJ Pharmacol Exp Ther30311801188PubMedGoogle Scholar
  219. Stenfors, C, Srinivasan, GR, Theodorsson, E, Mathe, AA 1992Electroconvulsive stimuli and brain peptides: effect of modification of seizure duration on neuropeptide Y, neurokinin A, substance P and neurotensinBrain Res596251258PubMedGoogle Scholar
  220. Stiller, CO, Linderoth, B, O’Connor, WT, Franck, J, Falkenberg, T, Ungerstedt, U, Brodin, E 1995Repeated spinal cord stimulation decreases the extracellular level of gamma-aminobutyric acid in the periaqueductal gray matter of freely moving ratsBrain Res699231241PubMedGoogle Scholar
  221. Stout, SC, Owens, MJ, Nemeroff, CB 1999Preprotachykinin-A and neurokinin 1 receptor mRNA expression are unchanged in rat forebrain after chronic antidepressant administrationSoc Neurosci Abstr251066Google Scholar
  222. Stout, SC, Owens, MJ, Nemeroff, CB 2001Neurokinin(1) receptor antagonists as potential antidepressantsAnnu Rev Pharmacol Toxicol41877906PubMedGoogle Scholar
  223. Takayama, H, Ota, Z, Ogawa, N 1986Effect of immobilization stress on neuropeptides and their receptors in rat central nervous systemRegul Pept15239248PubMedGoogle Scholar
  224. Takeda, Y, Blount, P, Sachais, BS, Hershey, AD, Raddatz, R, Krause, JE 1992Ligand binding kinetics of substance P and neurokinin A receptors stably expressed in Chinese hamster ovary cells and evidence for differential stimulation of inositol 1,4,5-trisphosphate and cyclic AMP second messenger responsesJ Neurochem59740745PubMedGoogle Scholar
  225. Teixeira, RM, Santos, AR, Ribeiro, SJ, Calixto, JB, Rae, GA, De Lima, TC 1996Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in miceEur J Pharmacol311714PubMedGoogle Scholar
  226. Teixeira, RM, De Lima, TC 2003Involvement of tachykinin NK1 receptor in the behavioral and immunological responses to swimming stress in miceNeuropeptides37307315PubMedGoogle Scholar
  227. Teixeira, RM, Duarte, FS, De Lima, TC 2004Behavioral and immunological effects of substance P in female and male micePharmacol Biochem Behav7919PubMedGoogle Scholar
  228. Torrens, Y, Beaujouan, JC, Besson, MJ, Michelot, R, Glowinski, J 1981Inhibitory effects of GABA, L-glutamic acid and nicotine on the potassium-evoked release of substance P in substantia nigra slices of the ratEur J Pharmacol71383392PubMedGoogle Scholar
  229. Unger, T, Carolus, S, Demmert, G, Ganten, D, Lang, RE, Maser-Gluth, C, Steinberg, H, Veelken, R 1988Substance P induces a cardiovascular defense reaction in the rat: pharmacological characterizationCirc Res63812820PubMedGoogle Scholar
  230. Valentino, RJ, Bey, V, Pernar, L, Commons, KG 2003Substance P acts through local circuits within the rat dorsal raphe nucleus to alter serotonergic neuronal activityJ Neurosci2371557159PubMedGoogle Scholar
  231. Van der Hart, MG, Czeh, B, de Biurrun, G, Michaelis, T, Watanabe, T, Natt, O, Frahm, J, Fuchs, E 2002Substance P receptor antagonist and clomipramine prevent stress-induced alterations in cerebral metabolites, cytogenesis in the dentate gyrus and hippocampal volumeMol Psychiatry7933941PubMedGoogle Scholar
  232. Van der Hart, MG, de Biurrun, G, Czeh, B, Rupniak, NM, den Boer, JA, Fuchs, E 2005Chronic psychosocial stress in tree shrews: effect of the substance P (NK1 receptor) antagonist L-760735 and clomipramine on endocrine and behavioral parametersPsychopharmacology181207216PubMedGoogle Scholar
  233. Varty, GB, Cohen-Williams, ME, Morgan, CA, Pylak, U, Duffy, RA, Lachowicz, JE, Carey, GJ, Coffin, VL 2002The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonistsNeuropsychopharmacology27371379PubMedGoogle Scholar
  234. Varty, GB, Cohen-Williams, ME, Hunter, JC 2003The antidepressant-like effects of neurokinin NK1 receptor antagonists in a gerbil tail suspension testBehav Pharmacol148795PubMedGoogle Scholar
  235. Vassout, A, Veenstra, S, Hauser, K, Ofner, S, Brugger, F, Schilling, W, Gentsch, C 2000NKP608: a selective NK-1 receptor antagonist with anxiolytic-like effects in the social interaction and social exploration test in ratsRegul Pept96716PubMedGoogle Scholar
  236. Vendruscolo, LF, Takahashi, RN, Bruske, GR, Ramos, A 2003Evaluation of the anxiolytic-like effect of NKP608, a NK1-receptor antagonist, in two rat strains that differ in anxiety-related behaviorsPsychopharmacology170287293PubMedGoogle Scholar
  237. Vertes, RP 1991A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the ratJ Comp Neurol313643668PubMedGoogle Scholar
  238. Walker, PD, Riley, LA, Hart, RP, Jonakait, GM 1991Serotonin regulation of neostriatal tachykinins following neonatal 6-hydroxydopamine lesionsBrain Res5573136PubMedGoogle Scholar
  239. Warden, MK, Young, WS 1988Distribution of cells containing mRNAs encoding substance P and neurokinin B in the rat central nervous systemJ Comp Neurol27290113PubMedGoogle Scholar
  240. Xin, L, Geller, EB, Liu-Chen, LY, Chen, C, Adler, MW 1997Substance P release in the rat periaqueductal gray and preoptic anterior hypothalamus after noxious cold stimulation: effect of selective mu and kappa opioid agonistsJ Pharmacol Exp Ther28210551063PubMedGoogle Scholar
  241. Zachrisson, O, Mathe, AA, Lindefors, N 1997Decreased levels of preprotachykinin-A and tachykinin NK1 receptor mRNA in specific region of the rat striatum after electroconvulsive stimuliEur J Pharmacol319191195PubMedGoogle Scholar
  242. Zernig, G, Dietrich, H, Maggi, CA, Saria, A 1992The substance P (NK1) receptor antagonist (±)-CP-96,345 causes sedation and motor impairment in Swiss albino mice in the black-and-white box behavioral paradigmNeurosci Lett143169172PubMedGoogle Scholar
  243. Zhang, Y, Lu, L, Furlonger, C, Wu, GE, Paige, CJ 2000Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesisNat Immunol1392397PubMedGoogle Scholar
  244. Zocchi, A, Varnier, G, Arban, R, Griffante, C, Zanetti, L, Bettelini, L, Marchi, M, Gerrard, PA, Corsi, M 2003Effects of antidepressant drugs and GR 205171, an neurokinin-1 (NK1) receptor antagonist, on the response in the forced swim test and on monoamine extracellular levels in the frontal cortex of the mouseNeurosci Lett3457376PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • K. Ebner
    • 1
  • N. Singewald
    • 1
  1. 1.Department of Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences Innsbruck (CMBI)University of InnsbruckInnsbruckAustria

Personalised recommendations